DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Exforge HCT (Amlodipine Besylate / Hydrochlorothiazide / Valsartan) - Published Studies

 
 



Exforge HCT Related Published Studies

Well-designed clinical trials related to Exforge HCT (Amlodipine / Hydrochlorothiazide / Valsartan)

24-Hour ambulatory blood pressure response to combination valsartan/hydrochlorothiazide and amlodipine/hydrochlorothiazide in stage 2 hypertension by ethnicity: the EVALUATE study. [2010.11]

Effects of force-titrated valsartan/hydrochlorothiazide versus amlodipine/hydrochlorothiazide on ambulatory blood pressure in patients with stage 2 hypertension: the EVALUATE study. [2009.06]

Clevidipine: a review of its use in the management of acute hypertension. [2009]

Well-designed clinical trials possibly related to Exforge HCT (Amlodipine / Hydrochlorothiazide / Valsartan)

Antihypertensive and metabolic effects of Angiotensin receptor blocker/diuretic combination therapy in obese, hypertensive African American and white patients. [2013]

Other research related to Exforge HCT (Amlodipine / Hydrochlorothiazide / Valsartan)

Effects of valsartan or ramipril addition to amlodipine/hydrochlorothiazide combination on left ventricular mass in diabetic hypertensive patients with left ventricular hypertrophy. [2012]

24-Hour ambulatory blood pressure control with triple-therapy amlodipine, valsartan and hydrochlorothiazide in patients with moderate to severe hypertension. [2011.10]

[Medication of the month. Exforge HCT: combination of amlodipine besylate, valsartan and hydrochlorothiazide in a single tablet]. [2010.07]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014